Prize Papers 13: New Drug Treatments & Technologies
This session will take place on 12th September at 09:00 CEST.
Chairperson(s): N. Eter GERMANY
09:00 Welcome and introduction
A. Tufail UK
09:01 Intravitreal Gene Therapy for Neovascular Age-related Macular Degeneration with ADVM-022: Results from the Phase 1 OPTIC Trial
D. Pieramici USA
09:05 Gene Therapy by Subretinal Delivery of RGX-314 for Neovascular AMD: End of Study Phase I/IIa Results
T. Jackson UK
09:15 A safety study of ONS-5010 for the treatment of wet age-related macular degeneration, diabetic macular oedema and branch retinal vein occlusion.
S. Mahapatra INDIA
09:19 Fifty two Weeks Safety and Efficacy of Ambient light sensitive Multi-Characteristic Opsin enabled vision restoration in patients with ABCA4 mutation
M. Melikhova RUSSIA
09:29 Comparison of the results of subthreshold micropulse laser coagulation in patients with various forms of macular degeneration
P. Tacata PHILLIPINES
09:33 Anatomical and Visual Outcomes of Filipino Patients with Acute Central Serous Chorioretinopathy Treated with Intravitreal Ranibizumab vs. Observation vs. Intravitreal Aflibercept : A Retrospective Cohort Study